A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

Health officials would like to remind you that we are entering that time of the year still quaintly known as flu season. That ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...

An increase in RSV infections has seen more babies admitted to hospital with severe chest infections, the UK Health Security ...

There has been a surge in cases of a deadly virus with more babies admitted to hospital, according to the UK Health Security ...

The UK Health Security Agency warns coughs, colds, flu, and Covid are already on the rise, and now norovirus cases are ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...

Rates of sudden infant deaths increased during the covid-19 pandemic, a new analysis suggests — and altered transmission of ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

The respiratory syncytial virus (RSV) vaccines were about 80% effective in older adults during the 2023-24 respiratory disease season, which was the first season after the shot was approved in the US, ...